A Portfolio of Winners, It Doesn’t Have to Be Complicated

By

Portfolio of WinnersIf you put a list together of some of the greatest blue chips the stock market has to offer, you might include The Procter & Gamble Company (NYSE/PG) among others. Procter & Gamble is just the kind of company that can thrive in a slow-growth environment. Institutional investors like it for its dividend (current yield is about 3.2%) and stability. The company offers predictability for stock market investors.

I remember when Procter & Gamble had a big miss in its quarterly earnings, right at the time when the bubble in technology stocks was bursting. The stock was basically cut in half and took a solid five years to recover—five full years, just to get back to where it was trading on the stock market before the breakdown. Even for a growing blue chip company, that’s a long time for investors.

This fiscal year, Procter & Gamble’s revenues and earnings are expected to be about flat with last year. Current expectations for fiscal year 2013 are for earnings-per-share (EPS) growth of approximately eight percent. Combined with its dividend, you could argue that this blue chip company is doing its job. The company’s stock market chart is below:

Procter & Gamble’s Company Chart

Chart courtesy of www.StockCharts.com

Other dividend paying blue chips with great track records on the stock market include Colgate-Palmolive Company (NYSE/CL), International Business Machines Corporation (NYSE/IBM), PepsiCo, Inc. (NYSE/PEP), and Johnson & Johnson (NYSE/JNJ). I would argue that all five of these blue chip stocks are worth considering when they’re down. With dividend reinvestment, I think this group makes for a great stock market portfolio.

Special: Military's "6th Branch" to Create 22,000 Millionaires Again? The military is mobilizing a new "6th Branch"—one unlike anything seen since World War II. The last time this happened, it minted 22,000 millionaires in just a few short years. Now history is repeating itself. The Pentagon is quietly unleashing $65 billion for this buildup... Using history as a guide, investors could see earth-shattering gains of up to 23,586%...enough to turn every $10,000 into $2,358,600 on just a single play. In fact, our investigation found the Pentagon's "6th Branch" buildup could already be minting new millionaires. So if you're looking to retire rich in the next few years...starting with very little money...you'll need to move quickly, before these stocks really take off and the opportunity is over. Take action while there's still time;Click here to get started now.

The one thing that’s in short supply these days is growth, and things are likely to remain low and slow for the next several years, possibly for the rest of this decade. (See “Where’s the Good News? Companies Just Meeting Expectations.”) This is why stability and size win in an environment like this. When business is slow, costs get squeezed and balance sheets typically improve. And with stability of cash flow, dividends get paid.

Large-cap blue chips have been particularly strong on the stock market since the financial crisis in 2008/2009. In spite of the doom and gloom back then, one of the best trades going was to ignore the hysteria and buy a basket of blue chips. It’s a simple, yet effective investment strategy that I believe in. Buy the best dividend paying companies in their field, and reinvest the quarterly dividend income in new shares. When the next recession comes, it will be an attractive buying opportunity for long-term investors.

About the Author, Browse Mitchell Clark's Articles

Mitchell Clark is a senior editor at Lombardi Financial, specializing in large- and micro-cap stocks. He’s the editor of a variety of popular Lombardi Financial newsletters, including Micro-Cap Reporter, Income for Life, Biotech Breakthrough Stock Report, and 100% Letter. Mitchell has been with Lombardi Financial for 17 years. He won the Jack Madden Prize in economic history and is a long-time student of equity markets. Prior to joining Lombardi, Mitchell was a stockbroker for a large investment bank. In the... Read Full Bio »

×